Published Studies Related to Ciclopirox Olamine (Ciclopirox Olamine Topical)
Well-designed clinical trials related to Ciclopirox Olamine (Ciclopirox Olamine Topical)
A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. [2010.09]
Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis. [2009.12]
Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. [2006.09]
Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study. [2006]
Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. [2005.07]
Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. [2005.07]
Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. [2005.01]
Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. [2005]
Well-designed clinical trials possibly related to Ciclopirox Olamine (Ciclopirox Olamine Topical)
Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. [2009.05]
Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study. [2005.06]
Other research related to Ciclopirox Olamine (Ciclopirox Olamine Topical)
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation. [2011.07]
The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. [2011.04]
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. [2010.11.12]
A Randomized, Double-Blind Study Comparing the Efficacy of Selenium Sulfide Shampoo 1% and Ciclopirox Shampoo 1% as Adjunctive Treatments for Tinea Capitis in Children. [2010.08.24]
Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. [2010.08]
Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer. [2010.05]
Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study. [2010.02]
A randomized, double-blind study comparing the efficacy of selenium sulfide
shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis
in children. [2010]
Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. [2009.11]
Iontophoretically enhanced ciclopirox delivery into and across human nail plate. [2009.10]
An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. [2009.07]
Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability of Ageratina pichinchensis Extract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox. [2008.10]
Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole. [2008.10]
Ototoxic effect of topical ciclopirox as an antimycotic preparation. [2008.10]
Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability of Ageratina pichinchensis Extract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox. [2008.07.31]
An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. [2007.11]
[Mucoadhesive tablets for oral administration of ciclopiroxolamine] [2007.10]
Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study. [2007.05]
Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. [2007]
Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%. [2006.07]
Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. [2006.01]
Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective. [2005.09]
The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis. [2005.03]
In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. [2005.01]
A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans. [2005.01]
Other possibly related research studies
Treatment costs of three nail lacquers used in onychomycosis. [2005]
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. [2005.01]
Majocchi's granuloma after kidney transplantation. [2006.12]
Toenail onychomycosis: current and future treatment options. [2007.01]
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani] [2006.12]
Trichophytic Majocchi granuloma mimicking Kaposi sarcoma. [2007.07]
In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate. [2007.10]
A case report of Hailey-Hailey disease treated with alefacept (Amevive). [2008.02]
Onychomycosis in the elderly : drug treatment options. [2007]
Review of antifungal therapy and the severity index for assessing onychomycosis: part I. [2008]
Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model. [2009.01]
Update in antifungal therapy of dermatophytosis. [2008.11]
Toenail onychomycosis in diabetic patients: issues and management. [2009]
Onychomycosis. [2010.03.04]
[Melanonychia: The purpose of a case of ungual mycotization mimicking melanoma] [2010.03.15]
Onychomycosis in a very young child. [2009.11]
Evaluation of a nonsteroidal topical cream in a guinea pig model of Malassezia furfur infection. [2009.11]
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity. [2010.02.01]
Onychomycosis and diabetes. [2009.10]
Nail infection by Aspergillus ochraceopetaliformis. [2009]
Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis. [2011.06]
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents. [2011.07]
Increased in vivo efficacy of lenalidomide by addition of piroctone olamine. [2011.01]
[Fungal diseases of vulva and vagina caused by Candida species]. [2010.09]
In vivo efficacy of griseofulvin against multiple myeloma. [2011.08]
Microsporum praecox: molecular identification of a new case and review of the literature. [2011.01]
Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents. [2010.06]
First case of Trichophyton soudanense isolated in Tunisia. [2010.11]
Topical antifungal agents for seborrheic dermatitis: systematic review and
meta-analysis. [2011]
|
